BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 20443461)

  • 1. Comparison of Bayesian network and support vector machine models for two-year survival prediction in lung cancer patients treated with radiotherapy.
    Jayasurya K; Fung G; Yu S; Dehing-Oberije C; De Ruysscher D; Hope A; De Neve W; Lievens Y; Lambin P; Dekker AL
    Med Phys; 2010 Apr; 37(4):1401-7. PubMed ID: 20443461
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and external validation of prognostic model for 2-year survival of non-small-cell lung cancer patients treated with chemoradiotherapy.
    Dehing-Oberije C; Yu S; De Ruysscher D; Meersschout S; Van Beek K; Lievens Y; Van Meerbeeck J; De Neve W; Rao B; van der Weide H; Lambin P
    Int J Radiat Oncol Biol Phys; 2009 Jun; 74(2):355-62. PubMed ID: 19095367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Support vector machine-based prediction of local tumor control after stereotactic body radiation therapy for early-stage non-small cell lung cancer.
    Klement RJ; Allgäuer M; Appold S; Dieckmann K; Ernst I; Ganswindt U; Holy R; Nestle U; Nevinny-Stickel M; Semrau S; Sterzing F; Wittig A; Andratschke N; Guckenberger M
    Int J Radiat Oncol Biol Phys; 2014 Mar; 88(3):732-8. PubMed ID: 24411630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bayesian network ensemble as a multivariate strategy to predict radiation pneumonitis risk.
    Lee S; Ybarra N; Jeyaseelan K; Faria S; Kopek N; Brisebois P; Bradley JD; Robinson C; Seuntjens J; El Naqa I
    Med Phys; 2015 May; 42(5):2421-30. PubMed ID: 25979036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microscopic disease extension in three dimensions for non-small-cell lung cancer: development of a prediction model using pathology-validated positron emission tomography and computed tomography features.
    van Loon J; Siedschlag C; Stroom J; Blauwgeers H; van Suylen RJ; Knegjens J; Rossi M; van Baardwijk A; Boersma L; Klomp H; Vogel W; Burgers S; Gilhuijs K
    Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):448-56. PubMed ID: 20971575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Impact of PET/CT on precise radiotherapy planning for non-small cell lung cancer].
    Gong HY; Yu JM; Fu Z; Li BS; Li JB; Liu TH
    Zhonghua Zhong Liu Za Zhi; 2006 Jan; 28(1):54-7. PubMed ID: 16737623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of different methods for delineation of 18F-FDG PET-positive tissue for target volume definition in radiotherapy of patients with non-Small cell lung cancer.
    Nestle U; Kremp S; Schaefer-Schuler A; Sebastian-Welsch C; Hellwig D; Rübe C; Kirsch CM
    J Nucl Med; 2005 Aug; 46(8):1342-8. PubMed ID: 16085592
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predicting distant failure in early stage NSCLC treated with SBRT using clinical parameters.
    Zhou Z; Folkert M; Cannon N; Iyengar P; Westover K; Zhang Y; Choy H; Timmerman R; Yan J; Xie XJ; Jiang S; Wang J
    Radiother Oncol; 2016 Jun; 119(3):501-4. PubMed ID: 27156652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of [18F]fluorodeoxyglucose PET-CT staging on treatment planning in radiotherapy incorporating elective nodal irradiation for non-small-cell lung cancer: a prospective study.
    Kolodziejczyk M; Kepka L; Dziuk M; Zawadzka A; Szalus N; Gizewska A; Bujko K
    Int J Radiat Oncol Biol Phys; 2011 Jul; 80(4):1008-14. PubMed ID: 20656419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical implications of defining the gross tumor volume with combination of CT and 18FDG-positron emission tomography in non-small-cell lung cancer.
    Grills IS; Yan D; Black QC; Wong CY; Martinez AA; Kestin LL
    Int J Radiat Oncol Biol Phys; 2007 Mar; 67(3):709-19. PubMed ID: 17197120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of computed tomography and 18F-deoxyglucose coincidence detection emission tomography image fusion for optimization of conformal radiotherapy in non-small-cell lung cancer.
    Deniaud-Alexandre E; Touboul E; Lerouge D; Grahek D; Foulquier JN; Petegnief Y; Grès B; El Balaa H; Keraudy K; Kerrou K; Montravers F; Milleron B; Lebeau B; Talbot JN
    Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1432-41. PubMed ID: 16125870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of hybrid fluorodeoxyglucose positron-emission tomography/computed tomography on radiotherapy planning in esophageal and non-small-cell lung cancer.
    Gondi V; Bradley K; Mehta M; Howard A; Khuntia D; Ritter M; Tomé W
    Int J Radiat Oncol Biol Phys; 2007 Jan; 67(1):187-95. PubMed ID: 17189070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modeling and predicting the occurrence of brain metastasis from lung cancer by Bayesian network: a case study of Taiwan.
    Wang KJ; Makond B; Wang KM
    Comput Biol Med; 2014 Apr; 47():147-60. PubMed ID: 24607682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 18F-FDG PET definition of gross tumor volume for radiotherapy of non-small cell lung cancer: is a single standardized uptake value threshold approach appropriate?
    Biehl KJ; Kong FM; Dehdashti F; Jin JY; Mutic S; El Naqa I; Siegel BA; Bradley JD
    J Nucl Med; 2006 Nov; 47(11):1808-12. PubMed ID: 17079814
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Machine learning for improved pathological staging of prostate cancer: a performance comparison on a range of classifiers.
    Regnier-Coudert O; McCall J; Lothian R; Lam T; McClinton S; N'dow J
    Artif Intell Med; 2012 May; 55(1):25-35. PubMed ID: 22206941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and validation of a prognostic model using blood biomarker information for prediction of survival of non-small-cell lung cancer patients treated with combined chemotherapy and radiation or radiotherapy alone (NCT00181519, NCT00573040, and NCT00572325).
    Dehing-Oberije C; Aerts H; Yu S; De Ruysscher D; Menheere P; Hilvo M; van der Weide H; Rao B; Lambin P
    Int J Radiat Oncol Biol Phys; 2011 Oct; 81(2):360-8. PubMed ID: 20888135
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Probability of mediastinal involvement in non-small-cell lung cancer: a statistical definition of the clinical target volume for 3-dimensional conformal radiotherapy?
    Giraud P; De Rycke Y; Lavole A; Milleron B; Cosset JM; Rosenzweig KE
    Int J Radiat Oncol Biol Phys; 2006 Jan; 64(1):127-35. PubMed ID: 16226394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Probabilistic modeling of short survivability in patients with brain metastasis from lung cancer.
    Makond B; Wang KJ; Wang KM
    Comput Methods Programs Biomed; 2015 May; 119(3):142-62. PubMed ID: 25804445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Seminal quality prediction using data mining methods.
    Sahoo AJ; Kumar Y
    Technol Health Care; 2014; 22(4):531-45. PubMed ID: 24898862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prognosis of locally advanced non small cell lung cancer treated with three dimentional conformal radiotherapy].
    Zhu XZ; Wang LH; Ou GF; Zhou ZM; Chen DF; Xiao ZF; Feng QF; Zhang HX; Wang M; Yin WB
    Zhonghua Zhong Liu Za Zhi; 2007 Oct; 29(10):748-53. PubMed ID: 18396686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.